Following discussion at the March 2024 meeting of CRG, we now seek comments on an updated shared care protocol for paliperidone long-acting injection.

Please also see the separate consultation on the addition of paliperidone palmitate 700mg & 1000mg to formulary as AMBER medicines.

All comments will be reviewed but please do not expect a personal reply as we do not routinely reply to all comments. It is important to include any relevant evidence to back up any suggestions and please keep comments concise where possible.

Please note

  1. The messages sent from this form are transmitted via our host’s web server. If you have any security concerns about this process you can send your comments/feedback using your own email client to
  2. This consultation will run for six weeks and closes at 5pm on Wednesday 24th April 2024.
Document Title Issue Date Review Date Status
Shared care protocol – Paliperidone palmitate long-acting injection 20240324 Mar 2024 20240424 Apr 2024 Draft for consultation